Comparison of Anti–SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine

Online journal article in Microbiology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Compare and discuss anti SARS-Cov-2 S1 Receptor-Binding Domain antibodies results obtained by different automated immunoassays.
Recognize the immune...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Compare and discuss anti SARS-Cov-2 S1 Receptor-Binding Domain antibodies results obtained by different automated immunoassays.
Recognize the immune response to SARS-COV-2 following vaccination, versus infection / disease seroconversion.
Confirm anti SARS-Cov-2 reaction after the BNT162b2 mRNA Vaccine, based on of Anti–SARS-CoV-2 S1 Receptor-Binding Domain antibody immunoassays.

View More View Less